Scholarlink

<p>Cardiovascular disease (CVD) is the leading global cause of death, encompassing heart attacks, strokes and coronary artery disease. While traditional photonic technologies such as angiography, computed tomography and laser ablation have long been used for CVD diagnosis and treatment, newer innovations are transforming the field. Emerging photonic technologies such as photoacoustic imaging, optical wearable sensors, point-of-care testing and optogenetic control offer non-invasive, high-resolution and high-throughput imaging along with precise therapeutic interventions. This Review highlights the broad applications of these photonic technologies in CVD care, discussing their potential to enhance precision and outcomes. It also addresses the challenges of integrating these innovations into clinical practice, focusing on trends including miniaturization and AI integration. These advancements are poised to revolutionize CVD management and reduce its global burden.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Emergent photonics for cardiovascular health

  • 期刊论文

  • 发表日期：

    2025年6月27日

查看全文
  • Yuqi Zhou,
  • Atsuhiro Nakagawa,
  • Masahiro Sonoshita,
  • Guillermo J. Tearney,
  • Aydogan Ozcan,
  • Keisuke Goda

摘要

Cardiovascular disease (CVD) is the leading global cause of death, encompassing heart attacks, strokes and coronary artery disease. While traditional photonic technologies such as angiography, computed tomography and laser ablation have long been used for CVD diagnosis and treatment, newer innovations are transforming the field. Emerging photonic technologies such as photoacoustic imaging, optical wearable sensors, point-of-care testing and optogenetic control offer non-invasive, high-resolution and high-throughput imaging along with precise therapeutic interventions. This Review highlights the broad applications of these photonic technologies in CVD care, discussing their potential to enhance precision and outcomes. It also addresses the challenges of integrating these innovations into clinical practice, focusing on trends including miniaturization and AI integration. These advancements are poised to revolutionize CVD management and reduce its global burden.